TD-4208 700 μg

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Chronic Obstructive Pulmonary Disease, COPD

Drug Information

Target Indication

Chronic Obstructive Pulmonary Disease, COPD

Clinical Trial

Last updated: 12/19/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VTRS

MYLAN

Related Pipeline

Hemophilia B

Smoking Cessation

Pneumococcal Disease

Overactive Bladder

Advanced Breast Cancer Female